In News

Follow this topic

Bookmark

Record learning outcomes

Accord Healthcare, one of Europe's fastest growing generic companies, is increasing its activity in the UK. Since the company launched its first product in the UK in 2008, its portfolio has increased by 233 per cent and now includes 150 products across multiple therapeutic areas. According to recently appointed vice president of Retail Europe, Accord Healthcare, Michael Cann, the company's growth is due to the fact that it controls all aspects of its supply chain, from manufacturing to production, enabling it to €offer high quality products at a very competitive price€.